TGFB1 and sarcomatoid carcinoma: These results suggest that endoglin acts to downmodulate TGFβ1 signaling in keratinocytes, and generating results similar to the TGFβ1+/− mice [47], during tumor progression enhances TGFβ1 signaling, EMT, and progression to spindle-cell carcinoma.